全球自闭症谱系障碍诊断市场研究报告 - 2024 年至 2032 年行业分析、规模、份额、成长、趋势和预测

全球自闭症谱系障碍诊断市场需求预计将从 2023 年的 275.2 亿美元增至 2032 年的近 448.2 亿美元，2024-2032 年研究期间CAGR为 5.57%。

自闭症谱系障碍 (ASD) 诊断涉及评估和识别个体自闭症相关特征。诊断过程可能包括行为观察、访谈和标准化测试，以评估沟通技巧、社交互动和重复行为。

市场动态

自闭症谱系障碍诊断市场是由自闭症谱系障碍日益流行、意识不断增强以及早期准确诊断的需求所推动的。这些诊断涉及一系列评估，包括行为评估、基因测试和神经影像学，以识别和表征个体的自闭症谱系障碍。人们日益认识到早期介入对于改善自闭症谱系障碍患者预后的重要性，刺激了对可靠、全面的诊断工具的需求。此外，医学影像技术的进步有助于准确、及时的诊断。医疗保健专业人员、教育工作者和家长对 ASD 的认识不断提高，进一步推动了对诊断的需求。对自闭症研究和诊断开发的监管支持也在市场成长中发挥关键作用。此外，正在进行的研究工作着重于识别生物标记、遗传因素和神经发育指标，旨在提高 ASD 诊断的精确度和效率，从而塑造该市场的发展轨迹。

研究报告涵盖波特五力模型、市场吸引力分析和价值链分析。这些工具有助于清晰地了解行业结构并评估全球范围内的竞争吸引力。此外，这些工具还对全球自闭症谱系障碍诊断市场的每个细分市场进行了包容性评估。自闭症谱系障碍诊断行业的成长和趋势为这项研究提供了整体方法。

市场区隔

自闭症谱系障碍诊断市场报告的这一部分提供了国家和地区层面细分市场的详细资料，从而帮助策略师确定相应产品或服务的目标人群以及即将到来的机会。

按类型

• 自闭症
• 亚斯伯格症
• 普遍性发展障碍（Pdd）
• 其他

按服务

• 行为方法
• 早期干涉
• 药物
• 其他

按分销管道

• 医院药房
• 药局和零售药局
• 网路药局

区域分析

本节涵盖区域前景，重点介绍北美、欧洲、亚太地区、拉丁美洲以及中东和非洲自闭症谱系障碍诊断市场当前和未来的需求。此外，该报告重点关注所有主要地区各个应用领域的需求、估计和预测。

该研究报告还涵盖了市场主要参与者的全面概况以及对全球竞争格局的深入了解。自闭症谱系障碍诊断市场的主要参与者包括Quest Diagnostics、Bio-Rad Laboratories、Thermo Fisher Scientific、F. Hoffmann-La Roche Ltd、Siemens Healthineers、Abbott Laboratories、Koninklijke Philips NV（飞利浦医疗保健）、PerkinElmer Inc. 、GE医疗保健、安捷伦科技等。本节包含竞争格局的整体视图，包括各种策略发展，例如关键併购、未来产能、合作伙伴关係、财务概况、合作、新产品开发、新产品发布和其他发展。

如果您有任何客製化要求，请写信给我们。我们的研究团队可以根据您的需求提供客製化报告。

目录

第一章：前言

• 报告说明
  • 客观的
  • 目标受众
  • 独特的销售主张 (USP) 和产品
• 研究范围
• 研究方法论
  • 市场研究过程
  • 市场研究方法论

第 2 章：执行摘要

• 市集亮点
• 全球市场概况

第 3 章：自闭症谱系障碍诊断 - 产业分析

• 简介 - 市场动态
• 市场驱动因素
• 市场限制
• 机会
• 产业动态
• 波特五力分析
• 市场吸引力分析
  • 按类型分類的市场吸引力分析
  • 按服务分類的市场吸引力分析
  • 按分销管道分類的市场吸引力分析
  • 市场吸引力分析：按地区

第 4 章：价值链分析

• 价值链分析
• 原料分析
  • 原料清单
  • 原料厂商清单
  • 主要原物料价格走势
• 潜在买家名单
• 行销管道
  • 直效行销
  • 间接行销
  • 行销通路发展趋势

第 5 章：全球自闭症谱系障碍诊断市场分析：按类型

• 按类型概述
• 历史和预测数据
• 按类型分析
• 自闭症
• 亚斯伯格症
• 普遍性发展障碍（PDD）
• 其他

第 6 章：全球自闭症谱系障碍诊断市场分析：依服务分类

• 按服务概览
• 历史和预测数据
• 按服务分析
• 行为方法
• 早期干涉
• 药物
• 其他

第 7 章：全球自闭症谱系障碍诊断市场分析：按分销管道

• 分销管道概述
• 历史和预测数据
• 按分销管道分析
• 医院药房
• 药局和零售药局
• 网路药局

第 8 章：全球自闭症谱系障碍诊断市场分析：依地理位置

• 区域展望
• 介绍
• 北美销售分析
  • 概览、历史与预测资料销售分析
  • 北美按细分市场销售分析
  • 北美按国家销售分析
  • 美国销售分析
  • 加拿大销售分析
  • 墨西哥销售分析
• 欧洲销售分析
  • 概览、历史与预测资料销售分析
  • 欧洲按细分市场销售分析
  • 欧洲按国家销售分析
  • 英国销售分析
  • 法国销售分析
  • 德国销售分析
  • 义大利销售分析
  • 俄罗斯销售分析
  • 欧洲其他地区销售分析
• 亚太地区销售分析
  • 概览、历史与预测资料销售分析
  • 亚太地区按细分市场销售分析
  • 亚太地区国家/地区销售分析
  • 中国销售分析
  • 印度销售分析
  • 日本销售分析
  • 韩国销售分析
  • 澳洲销售分析
  • 东南亚销售分析
  • 亚太地区其他地区销售分析
• 拉丁美洲销售分析
  • 概览、历史与预测资料销售分析
  • 拉丁美洲按细分市场销售分析
  • 拉丁美洲按国家销售分析
  • 巴西销售分析
  • 阿根廷销售分析
  • 秘鲁销售分析
  • 智利销售分析
  • 拉丁美洲其他地区销售分析
• 中东和非洲销售分析
  • 概览、历史与预测资料销售分析
  • 中东和非洲按细分市场销售分析
  • 中东和非洲国家销售分析
  • 沙乌地阿拉伯销售分析
  • 阿联酋销售分析
  • 以色列销售分析
  • 南非销售分析
  • 中东其他地区和非洲销售分析

第 9 章：自闭症谱系障碍诊断公司的竞争格局

• 自闭症谱系障碍诊断市场竞争
• 伙伴关係/协作/协议
• 併购
• 新产品发布
• 其他发展

第 10 章：公司简介

• 公司股份分析
• 市场集中度
• Quest Diagnostics
• 公司简介
• 公司收入
• 产品
• 最近的发展
• Bio-Rad Laboratories
• 公司简介
• 公司收入
• 产品
• 最近的发展
• Thermo Fisher Scientific
• 公司简介
• 公司收入
• 产品
• 最近的发展
• F. Hoffmann-La Roche Ltd
• 公司简介
• 公司收入
• 产品
• 最近的发展
• Siemens Healthineers
• 公司简介
• 公司收入
• 产品
• 最近的发展
• Abbott Laboratories
• 公司简介
• 公司收入
• 产品
• 最近的发展
• Koninklijke Philips NV (Philips Healthcare)
• 公司简介
• 公司收入
• 产品
• 最近的发展
• PerkinElmer Inc.
• 公司简介
• 公司收入
• 产品
• 最近的发展
• GE Healthcare
• 公司简介
• 公司收入
• 产品
• 最近的发展

注意 - 在公司概况中，财务详细资讯和近期发展视情况而定，或者如果是私人公司，则可能不包括在内

The global demand for Autism Spectrum Disorder Diagnostics Market is presumed to reach the market size of nearly USD 44.82 BN by 2032 from USD 27.52 BN in 2023 with a CAGR of 5.57% under the study period 2024 - 2032.

Autism Spectrum Disorder (ASD) Diagnostics involve the assessment and identification of autism-related characteristics in individuals. Diagnostic processes may include behavioral observations, interviews, and standardized tests to evaluate communication skills, social interactions, and repetitive behaviors.

MARKET DYNAMICS

The Autism Spectrum Disorder Diagnostics market is driven by the increasing prevalence of ASD, growing awareness, and the need for early and accurate diagnosis. These diagnostics involve a range of assessments, including behavioral evaluations, genetic testing, and neuroimaging, to identify and characterize autism spectrum disorders in individuals. The rising recognition of the importance of early intervention in improving outcomes for individuals with ASD stimulates the demand for reliable and comprehensive diagnostic tools. Additionally, advancements in medical imaging technologies contribute to accurate and timely diagnoses. The expanding awareness of ASD across healthcare professionals, educators, and parents further fuels the demand for diagnostics. Regulatory support for autism research and diagnostic development also plays a pivotal role in market growth. Moreover, ongoing research efforts focused on identifying biomarkers, genetic factors, and neurodevelopmental indicators aim to enhance the precision and efficiency of ASD diagnostics, shaping the trajectory of this market.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of autism spectrum disorder diagnostics. The growth and trends of autism spectrum disorder diagnostics industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the autism spectrum disorder diagnostics market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Type

• Autistic Disorder
• Asperger Syndrome
• Pervasive Development Disorder (Pdd)
• Other

By Service

• Behavioral Approaches
• Early Intervention
• Medication
• Other

By Distribution Channe

• Hospital Pharmacies
• Drug Stores And Retail Pharmacies
• Online Pharmacies

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Autism Spectrum Disorder Diagnostics market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Autism Spectrum Disorder Diagnostics market include Quest Diagnostics, Bio-Rad Laboratories, Thermo Fisher Scientific, F. Hoffmann-La Roche Ltd, Siemens Healthineers, Abbott Laboratories, Koninklijke Philips N.V. (Philips Healthcare), PerkinElmer Inc., GE Healthcare, Agilent Technologies, and others. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1 . PREFACE

• 1.1. Report Description
  • 1.1.1. Objective
  • 1.1.2. Target Audience
  • 1.1.3. Unique Selling Proposition (USP) & offerings
• 1.2. Research Scope
• 1.3. Research Methodology
  • 1.3.1. Market Research Process
  • 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

• 2.1. Highlights of Market
• 2.2. Global Market Snapshot

3 . AUTISM SPECTRUM DISORDER DIAGNOSTICS - INDUSTRY ANALYSIS

• 3.1. Introduction - Market Dynamics
• 3.2. Market Drivers
• 3.3. Market Restraints
• 3.4. Opportunities
• 3.5. Industry Trends
• 3.6. Porter's Five Force Analysis
• 3.7. Market Attractiveness Analysis
  • 3.7.1 Market Attractiveness Analysis By Type
  • 3.7.2 Market Attractiveness Analysis By Service
  • 3.7.3 Market Attractiveness Analysis By Distribution Channe
  • 3.7.4 Market Attractiveness Analysis By Region

4 . VALUE CHAIN ANALYSIS

• 4.1. Value Chain Analysis
• 4.2. Raw Material Analysis
  • 4.2.1. List of Raw Materials
  • 4.2.2. Raw Material Manufactures List
  • 4.2.3. Price Trend of Key Raw Materials
• 4.3. List of Potential Buyers
• 4.4. Marketing Channel
  • 4.4.1. Direct Marketing
  • 4.4.2. Indirect Marketing
  • 4.4.3. Marketing Channel Development Trend

5 . GLOBAL AUTISM SPECTRUM DISORDER DIAGNOSTICS MARKET ANALYSIS BY TYPE

• 5.1 Overview by Type
• 5.2 Historical and Forecast Data
• 5.3 Analysis by Type
• 5.4 Autistic Disorder Historic and Forecast Sales by Regions
• 5.5 Asperger Syndrome Historic and Forecast Sales by Regions
• 5.6 Pervasive Development Disorder (PDD) Historic and Forecast Sales by Regions
• 5.7 Other Historic and Forecast Sales by Regions

6 . GLOBAL AUTISM SPECTRUM DISORDER DIAGNOSTICS MARKET ANALYSIS BY SERVICE

• 6.1 Overview by Service
• 6.2 Historical and Forecast Data
• 6.3 Analysis by Service
• 6.4 Behavioral Approaches Historic and Forecast Sales by Regions
• 6.5 Early Intervention Historic and Forecast Sales by Regions
• 6.6 Medication Historic and Forecast Sales by Regions
• 6.7 Other Historic and Forecast Sales by Regions

7 . GLOBAL AUTISM SPECTRUM DISORDER DIAGNOSTICS MARKET ANALYSIS BY DISTRIBUTION CHANNE

• 7.1 Overview by Distribution Channe
• 7.2 Historical and Forecast Data
• 7.3 Analysis by Distribution Channe
• 7.4 Hospital Pharmacies Historic and Forecast Sales by Regions
• 7.5 Drug Stores and Retail Pharmacies Historic and Forecast Sales by Regions
• 7.6 Online Pharmacies Historic and Forecast Sales by Regions

8 . GLOBAL AUTISM SPECTRUM DISORDER DIAGNOSTICS MARKET ANALYSIS BY GEOGRAPHY

• 8.1. Regional Outlook
• 8.2. Introduction
• 8.3. North America Sales Analysis
  • 8.3.1. Overview, Historic and Forecast Data Sales Analysis
  • 8.3.2. North America By Segment Sales Analysis
  • 8.3.3. North America By Country Sales Analysis
  • 8.3.4. United State Sales Analysis
  • 8.3.5. Canada Sales Analysis
  • 8.3.6. Mexico Sales Analysis
• 8.4. Europe Sales Analysis
  • 8.4.1. Overview, Historic and Forecast Data Sales Analysis
  • 8.4.2. Europe by Segment Sales Analysis
  • 8.4.3. Europe by Country Sales Analysis
  • 8.4.4. United Kingdom Sales Analysis
  • 8.4.5. France Sales Analysis
  • 8.4.6. Germany Sales Analysis
  • 8.4.7. Italy Sales Analysis
  • 8.4.8. Russia Sales Analysis
  • 8.4.9. Rest Of Europe Sales Analysis
• 8.5. Asia Pacific Sales Analysis
  • 8.5.1. Overview, Historic and Forecast Data Sales Analysis
  • 8.5.2. Asia Pacific by Segment Sales Analysis
  • 8.5.3. Asia Pacific by Country Sales Analysis
  • 8.5.4. China Sales Analysis
  • 8.5.5. India Sales Analysis
  • 8.5.6. Japan Sales Analysis
  • 8.5.7. South Korea Sales Analysis
  • 8.5.8. Australia Sales Analysis
  • 8.5.9. South East Asia Sales Analysis
  • 8.5.10. Rest Of Asia Pacific Sales Analysis
• 8.6. Latin America Sales Analysis
  • 8.6.1. Overview, Historic and Forecast Data Sales Analysis
  • 8.6.2. Latin America by Segment Sales Analysis
  • 8.6.3. Latin America by Country Sales Analysis
  • 8.6.4. Brazil Sales Analysis
  • 8.6.5. Argentina Sales Analysis
  • 8.6.6. Peru Sales Analysis
  • 8.6.7. Chile Sales Analysis
  • 8.6.8. Rest of Latin America Sales Analysis
• 8.7. Middle East & Africa Sales Analysis
  • 8.7.1. Overview, Historic and Forecast Data Sales Analysis
  • 8.7.2. Middle East & Africa by Segment Sales Analysis
  • 8.7.3. Middle East & Africa by Country Sales Analysis
  • 8.7.4. Saudi Arabia Sales Analysis
  • 8.7.5. UAE Sales Analysis
  • 8.7.6. Israel Sales Analysis
  • 8.7.7. South Africa Sales Analysis
  • 8.7.8. Rest Of Middle East And Africa Sales Analysis

9 . COMPETITIVE LANDSCAPE OF THE AUTISM SPECTRUM DISORDER DIAGNOSTICS COMPANIES

• 9.1. Autism Spectrum Disorder Diagnostics Market Competition
• 9.2. Partnership/Collaboration/Agreement
• 9.3. Merger And Acquisitions
• 9.4. New Product Launch
• 9.5. Other Developments

10 . COMPANY PROFILES OF AUTISM SPECTRUM DISORDER DIAGNOSTICS INDUSTRY

• 10.1. Company Share Analysis
• 10.2. Market Concentration Rate
• 10.3. Quest Diagnostics
  • 10.3.1. Company Overview
  • 10.3.2. Company Revenue
  • 10.3.3. Products
  • 10.3.4. Recent Developments
• 10.4. Bio-Rad Laboratories
  • 10.4.1. Company Overview
  • 10.4.2. Company Revenue
  • 10.4.3. Products
  • 10.4.4. Recent Developments
• 10.5. Thermo Fisher Scientific
  • 10.5.1. Company Overview
  • 10.5.2. Company Revenue
  • 10.5.3. Products
  • 10.5.4. Recent Developments
• 10.6. F. Hoffmann-La Roche Ltd
  • 10.6.1. Company Overview
  • 10.6.2. Company Revenue
  • 10.6.3. Products
  • 10.6.4. Recent Developments
• 10.7. Siemens Healthineers
  • 10.7.1. Company Overview
  • 10.7.2. Company Revenue
  • 10.7.3. Products
  • 10.7.4. Recent Developments
• 10.8. Abbott Laboratories
  • 10.8.1. Company Overview
  • 10.8.2. Company Revenue
  • 10.8.3. Products
  • 10.8.4. Recent Developments
• 10.9. Koninklijke Philips N.V. (Philips Healthcare)
  • 10.9.1. Company Overview
  • 10.9.2. Company Revenue
  • 10.9.3. Products
  • 10.9.4. Recent Developments
• 10.10. PerkinElmer Inc.
  • 10.10.1. Company Overview
  • 10.10.2. Company Revenue
  • 10.10.3. Products
  • 10.10.4. Recent Developments
• 10.11. GE Healthcare
  • 10.11.1. Company Overview
  • 10.11.2. Company Revenue
  • 10.11.3. Products
  • 10.11.4. Recent Developments

Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies

LIST OF TABLES

• Market Snapshot
• Drivers : Impact Analysis
• Restraints : Impact Analysis
• List of Raw Material
• List of Raw Material Manufactures
• List of Potential Buyers
• Analysis by Type (USD MN)
• Autistic Disorder Market Sales by Geography (USD MN)
• Asperger Syndrome Market Sales by Geography (USD MN)
• Pervasive Development Disorder (PDD) Market Sales by Geography (USD MN)
• Other Market Sales by Geography (USD MN)
• Analysis Market by Service (USD MN)
• Behavioral Approaches Market Sales by Geography (USD MN)
• Early Intervention Market Sales by Geography (USD MN)
• Medication Market Sales by Geography (USD MN)
• Other Market Sales by Geography (USD MN)
• Analysis by Distribution Channe (USD MN)
• Hospital Pharmacies Market Sales by Geography (USD MN)
• Drug Stores and Retail Pharmacies Market Sales by Geography (USD MN)
• Online Pharmacies Market Sales by Geography (USD MN)
• Global Autism Spectrum Disorder Diagnostics Market Sales by Geography (USD MN)
• North America Market Analysis (USD MN)
• United State Market Analysis (USD MN)
• Canada Market Analysis (USD MN)
• Mexico Market Analysis (USD MN)
• Europe Market Analysis (USD MN)
• Europe Market Estimate by Country (USD MN)
• United Kingdom Market Analysis (USD MN)
• France Market Analysis (USD MN)
• Germany Market Analysis (USD MN)
• Italy Market Analysis (USD MN)
• Russia Market Analysis (USD MN)
• Spain Market Analysis (USD MN)
• Rest of Europe Market Analysis (USD MN)
• Asia Pacific Market Analysis (USD MN)
• China Market Analysis (USD MN)
• Japan Market Analysis (USD MN)
• India Market Analysis (USD MN)
• South Korea Market Analysis (USD MN)
• Australia Market Analysis (USD MN)
• South East Asia Market Analysis (USD MN)
• Rest of Asia Pacific Market Analysis (USD MN)
• Latin America Market Analysis (USD MN)
• Brazil Market Analysis (USD MN)
• Argentina Market Analysis (USD MN)
• Peru Market Analysis (USD MN)
• Chile Market Analysis (USD MN)
• Rest of Latin America Market Analysis (USD MN)
• Middle East & Africa Market Analysis (USD MN)
• Saudi Arabia Market Analysis (USD MN)
• UAE Market Analysis (USD MN)
• Israel Market Analysis (USD MN)
• South Africa Market Analysis (USD MN)
• Rest of Middle East and Africa Market Analysis (USD MN)
• Partnership/Collaboration/Agreement
• Mergers And Acquisition

LIST OF FIGURES

• Research Scope of Autism Spectrum Disorder Diagnostics Report
• Market Research Process
• Market Research Methodology
• Global Autism Spectrum Disorder Diagnostics Market Size, by Region (USD MN)
• Porters Five Forces Analysis
• Market Attractiveness Analysis by Type
• Market Attractiveness Analysis by Service
• Market Attractiveness Analysis by Distribution Channe
• Market Attractiveness Analysis by Region
• Value Chain Analysis
• Global Market Analysis by Type (USD MN)
• Autistic Disorder Market Sales by Geography (USD MN)
• Asperger Syndrome Market Sales by Geography (USD MN)
• Pervasive Development Disorder (PDD) Market Sales by Geography (USD MN)
• Other Market Sales by Geography (USD MN)
• Global Market Analysis by Service (USD MN)
• Behavioral Approaches Market Sales by Geography (USD MN)
• Early Intervention Market Sales by Geography (USD MN)
• Medication Market Sales by Geography (USD MN)
• Other Market Sales by Geography (USD MN)
• Global Market Analysis by Distribution Channe (USD MN)
• Hospital Pharmacies Market Sales by Geography (USD MN)
• Drug Stores and Retail Pharmacies Market Sales by Geography (USD MN)
• Online Pharmacies Market Sales by Geography (USD MN)
• Global Market Sales (USD MN)
• North America Market Sales (USD MN)
• Europe Market Sales (USD MN)
• Asia Pacific Market Sales (USD MN)
• Latin America Market Sales (USD MN)
• Middle East & Africa Market Sales (USD MN)
• Recent Development in Industry
• Top Company Market Share Analysis

Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.